| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JM9604080 |
| P698 | PubMed publication ID | 8831755 |
| P50 | author | Iwao Ojima | Q1676049 |
| P2093 | author name string | P Vrignaud | |
| P Pera | |||
| R J Bernacki | |||
| M C Bissery | |||
| E Michaud | |||
| P Y Bounaud | |||
| S D Kuduk | |||
| J C Slater | |||
| J M Veith | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3889-3896 | |
| P577 | publication date | 1996-09-01 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells | |
| P478 | volume | 39 |
| Q35123238 | A common pharmacophore for cytotoxic natural products that stabilize microtubules |
| Q30607577 | A structure-based design of new C2- and C13-substituted taxanes: tubulin binding affinities and extended quantitative structure-activity relationships using comparative binding energy (COMBINE) analysis. |
| Q42095730 | Advances in the chemistry of β-lactam and its medicinal applications. |
| Q36316831 | Antibody-cytotoxic agent conjugates for cancer therapy |
| Q36621623 | Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors |
| Q59183001 | Biodistribution and Pharmacokinetic Evaluations of a Novel Taxoid DHA-SBT-1214 in an Oil-in-Water Nanoemulsion Formulation in Naïve and Tumor-Bearing Mice |
| Q36937517 | Caspase-2 is involved in cell death induction by taxanes in breast cancer cells |
| Q34148034 | Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells. |
| Q36111203 | Chamaejasmin B exerts anti-MDR effect in vitro and in vivo via initiating mitochondria-dependant intrinsic apoptosis pathway |
| Q34564374 | Chemistry and chemical biology of taxane anticancer agents. |
| Q40458887 | CoMFA, HQSAR and molecular docking studies of butitaxel analogues with beta-tubulin. |
| Q40479447 | Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. |
| Q92795542 | DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model |
| Q38927851 | Dendritic polyglycerol sulfate as a novel platform for paclitaxel delivery: pitfalls of ester linkage. |
| Q35110101 | Design, Synthesis and Application of Fluorine-Labeled Taxoids as (19)F NMR Probes for the Metabolic Stability Assessment of Tumor-Targeted Drug Delivery Systems |
| Q54957223 | Design, Synthesis, and Biological Evaluations of Asymmetric Bow-Tie PAMAM Dendrimer-Based Conjugates for Tumor-Targeted Drug Delivery. |
| Q37325768 | Design, synthesis, and biological evaluation of new-generation taxoids |
| Q37329222 | Design, synthesis, and biological evaluation of novel C14-C3'BzN-linked macrocyclic taxoids |
| Q35175462 | Design, synthesis, and biological evaluation of theranostic vitamin-linker-taxoid conjugates |
| Q33894592 | Design, synthesis, and biological evaluations of tumor-targeting dual-warhead conjugates for a taxoid-camptothecin combination chemotherapy |
| Q33543346 | Differential effects of Paclitaxel on dendritic cell function |
| Q34143487 | Drug discovery targeting cell division proteins, microtubules and FtsZ. |
| Q52123962 | Effects of novel taxanes SB-T-1213 and IDN5109 on tubulin polymerization and mitosis. |
| Q43706843 | Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance |
| Q59183374 | Enantiopure fluorine-containing taxoids: potent anticancer agents and versatile probes for biomedical problems |
| Q37118460 | Exploration of fluorine chemistry at the multidisciplinary interface of chemistry and biology. |
| Q48176143 | Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes. |
| Q37074780 | Fluorine-Containing Taxoid Anticancer Agents and Their Tumor-Targeted Drug Delivery |
| Q33925595 | Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery. |
| Q44619969 | Improved Chemical Strategies for the Targeted Therapy of Cancer |
| Q50959398 | Intracellular Self-Assembly of Taxol Nanoparticles for Overcoming Multidrug Resistance. |
| Q44247312 | Investigation of structural requirements of anticancer activity at the paclitaxel/tubulin binding site using CoMFA and CoMSIA. |
| Q38255590 | Lipid-based drug carriers for prodrugs to enhance drug delivery |
| Q34565264 | Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. |
| Q38047388 | Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies |
| Q37841631 | Modulation of protein-protein interactions as a therapeutic strategy for the treatment of neurodegenerative tauopathies |
| Q37238550 | Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin |
| Q34432179 | Novel molecules that interact with microtubules and have functional activity similar to Taxol |
| Q34999208 | Overcoming multidrug resistance in taxane chemotherapy |
| Q36858404 | Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters |
| Q44591027 | Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors. |
| Q40154203 | Overcoming tumor drug resistance with high-affinity taxanes: a SAR study of C2-modified 7-acyl-10-deacetyl cephalomannines. |
| Q41998110 | Paclitaxel C-10 carbamates: potential candidates for the treatment of neurodegenerative tauopathies |
| Q60684474 | Paclitaxel analogues from Taxus baccata |
| Q36832450 | Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes |
| Q52690917 | Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery. |
| Q37400110 | Recent advances in the chemistry and biology of new generation taxoids |
| Q34769728 | Recent advances in the study of the bioactive conformation of taxol |
| Q90183783 | Recent progress in the strategic incorporation of fluorine into medicinally active compounds |
| Q37711937 | SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells |
| Q28574018 | Second-generation taxanes effectively suppress subcutaneous rat lymphoma: role of disposition, transport, metabolism, in vitro potency and expression of angiogenesis genes |
| Q38694536 | Strategic Incorporation of Fluorine into Taxoid Anticancer Agents for Medicinal Chemistry and Chemical Biology Studies |
| Q44466661 | Structure-activity relationship study of taxoids for their ability to activate murine macrophages as well as inhibit the growth of macrophage-like cells |
| Q52602328 | Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel. |
| Q37193056 | Syntheses and Structure-Activity Relationships of Novel 3'-Difluoromethyl and 3'-Trifluoromethyl-Taxoids |
| Q40856350 | Syntheses and biological activity of C-3'-difluoromethyl-taxoids. |
| Q36372764 | Synthesis and Biological Evaluation of Novel 3'-Difluorovinyl Taxoids |
| Q57607815 | Synthesis and bioactivities of paclitaxel analogs with a cyclopropanated side-chain |
| Q59183426 | Synthesis and biological activity of novel 3′-trifluoromethyl taxoids |
| Q44892653 | Synthesis and biological evaluation of C-3'NH/C-10 and C-2/C-10 modified paclitaxel analogues. |
| Q57445120 | Synthesis and biological evaluation of amide-linked A-norpaclitaxels |
| Q54110395 | Synthesis and evaluation of artificial taxoids with antitumor and multi-drug resistance reversing activities. |
| Q31942379 | Synthesis and evaluation of paclitaxel C7 derivatives: solution phase synthesis of combinatorial libraries |
| Q59183369 | Synthesis and structure-activity relationships of new second-generation taxoids |
| Q40877977 | Synthesis of highly potent second-generation taxoids through effective kinetic resolution coupling of racemic beta-lactams with baccatins |
| Q60684470 | Synthesis of paclitaxel (docetaxel) / 2-deacetoxytaxinine J dimers |
| Q52667194 | Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein. |
| Q34587678 | The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies |
| Q40634305 | The discovery of BMS-275183: an orally efficacious novel taxane |
| Q35085574 | The role of individual caspases in cell death induction by taxanes in breast cancer cells. |
| Q40390831 | Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells |
| Q39303893 | Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells |
| Q35765100 | Tumor-targeting drug delivery of new-generation taxoids |
| Q35762544 | Use of fluorine in the medicinal chemistry and chemical biology of bioactive compounds--a case study on fluorinated taxane anticancer agents |
| Q40873183 | Will natural products remain an important source of drug research for the future? |
Search more.